CN101194996A

CN101194996A - Chinese medicine ejection preparation and method for preparing the same

Info

Publication number: CN101194996A
Application number: CNA2006101443553A
Authority: CN
Inventors: 于文风
Original assignee: Qiyuanyide Medicines Institute Beijing
Current assignee: Qiyuanyide Medicines Institute Beijing
Priority date: 2006-12-04
Filing date: 2006-12-04
Publication date: 2008-06-11

Abstract

The invention relates to a traditional Chinese medicine injection for improving body immunity and curing cardio-cerebrovascular disease and process for preparation, which comprises liriope, ginseng or red ginseng or lanceolata, schisandra and breviscapine. The invention purposively extracts polysaccharide compositions in liriope medicinal materials without extraction of volatile oil composition in schisandra medicinal materials alone. Compared with the prior art, the invention has simple compatibility, good curative effect, no toxic and side effects, which is reasonable and feasible. The invention provides process for preparing different dosage forms, enlarges employing area, and has wide application scope. After experiments, the invention is found to have the functions of increasing body immunity, improving myocardial and brain tissue metabolism, increasing blood flow of coronary and cerebrovascular, and improving blood supply of myocardial, brain tissue and the like, which also has a good curative effect for curing cardio-cerebrovascular disease such as coronary heart disease, angina pectoris, arrhythmia, cerebral thrombosis, senile dementia and the like.

Description

A kind of traditional medicine Injectio and preparation method thereof

Technical field

The present invention is a kind of traditional medicine Injectio with human body immunity improving power, treatment cardiovascular and cerebrovascular disease and preparation method thereof, belongs to technical field of Chinese medicine.

Technical background

We suit the medicine to the illness--and-cardiovascular and cerebrovascular disease is a big persistent ailment that threatens world's healthy population as coronary heart disease, myocardial infarction, rhomboembolia type cerebrovascular, and the trend that progressively rises is arranged in recent years.The height of cardiovascular and cerebrovascular disease mortality rate is to weigh a country, resident's quality of life, the important indicator of sanitary health career, along with the arriving of fairly comfortable life, and the change of meals spectrum, resident's longevity, healthy existence desire improve constantly.In order to prevent, control the generation of cardiovascular and cerebrovascular disease, exploitation cardiovascular and cerebrovascular disease class medicine has become a main trend.So far existing a large amount of Chinese medicine and western medicine emerge.Therefore, it is low to seek a kind of cost, determined curative effect, the natural Chinese medicines preparation that has no side effect is very urgent, contrast after deliberation, we develop a kind of traditional medicine Injectio with human body immunity improving power, treatment cardiovascular and cerebrovascular disease, are made up of Radix Ophiopogonis, Radix Ginseng, Herba Erigerontis and Fructus Schisandrae Chinensis.Many inventors have also done number of research projects, as: number of patent application is " 02153750.X ", name is called the application of " a kind of Herba Erigerontis combination drug ", though the product of this part application has good clinical application effect, but the harm that cardiovascular and cerebrovascular disease acute attack at present brings to human health is bigger, oral formulations can't discharge medicine rapidly, lie in a comatose condition owing to the patient simultaneously, dysphagia, medicine disintegrate in gastrointestinal tract in addition, absorption are individual processes slowly, therefore can't reach the curative effect that needs.Because the continuing to optimize and develop of the process conditions of preparation breviscapine, a large amount of in addition clinical test results makes this raw materials quality controllability improve greatly.The inventor of present technique is by a large amount of experimental studies, invented with breviscapine and Chinese medicine Radix Ginseng, Radix Ophiopogonis, the crude extract of Fructus Schisandrae Chinensis or the ejection preparation of refining extract combination, modern extraction technique is combined with the Chinese medicine compound recipe, under safety, quality controllable prerequisite, make the effectiveness of the preparation after the combination improve greatly.

Summary of the invention

The object of the present invention is to provide a kind of traditional medicine Injectio and preparation method thereof with human body immunity improving power, treatment cardiovascular and cerebrovascular disease; The present invention is directed to prior art, at different medical materials, adopt the mode of separately extracting, can effectively extract active component, simultaneously can be under the situation that guarantees active component, remove impurity targetedly, sample is made with extra care, add that the treatment of cardiovascular and cerebrovascular disease acute attack stage is extremely important, preparation of the present invention is mainly injection, make medicine performance curative effect fast, the availability height is fit to the treatment of cardiovascular and cerebrovascular disease.In addition, the present invention adopts, and nontoxic, non-corrosive solvent extracts and makes with extra care, and makes that organic solvent-free is residual in the sample, improves the safety and the stability of preparation greatly, is convenient to production, packing, storage and the use of preparation.

Technical solution of the present invention is achieved in that according to components by weight percent and calculates, it is refiningly added suitable adjuvant and is made through extracting by 0.1～30 part of 1～300 part of 10～500 parts of Radix Ophiopogonis, 1～300 part of Radix Ginseng, Fructus Schisandrae Chinensis and breviscapine, or add suitable adjuvant and be made through extracting the extract that obtains after refining and corresponding weight portion breviscapine by corresponding weight portion medical material, and contain the various saccharides composition in the preparation, do not extract the Fructus Schisandrae Chinensis volatile oil constituents separately.Described traditional medicine Injectio with human body immunity improving power, treatment cardiovascular and cerebrovascular disease, calculate according to components by weight percent, it is refiningly added suitable adjuvant and is made through extracting by 0.3～15 part of 10～100 parts of 50～200 parts of Radix Ophiopogonis, 10～100 parts of Radix Ginsengs, Fructus Schisandrae Chinensis and breviscapine, or add suitable adjuvant and be made through extracting the extract that obtains after refining and corresponding weight portion breviscapine by corresponding weight portion medical material, and contain various saccharides compositions such as Radix Ophiopogonis polysaccharide and monosaccharide in the preparation, do not extract the Fructus Schisandrae Chinensis volatile oil constituents separately.Specifically, calculate according to components by weight percent, it is by 80～150 parts of Radix Ophiopogonis, 30～80 parts of Radix Ginsengs, 0.5～8 part of 30～80 parts of Fructus Schisandrae Chinensis and breviscapine are made through extracting refining and adding suitable adjuvant, or add suitable adjuvant and be made through extracting the extract that obtains after refining and corresponding weight portion breviscapine by corresponding weight portion medical material, and contain various saccharides compositions such as Radix Ophiopogonis polysaccharide and monosaccharide in the preparation, do not extract the Fructus Schisandrae Chinensis volatile oil constituents separately, calculate according to weight ratio, the content of carbohydrate content is not less than 4% of the total solid after the deduction adjuvant amount and water quantities in the preparation.

The Radix Ginseng that the present invention relates to can also be the Radix Ginseng Rubra or the Radix Codonopsis of equivalent.

Preparation of the present invention is an injection, comprising: be directly used in drug administration by injection injection, need to be used for after the dilution concentrated solution for injection of intravenous drip, directly for the glucose intravenous infusion of intravenous drip and sodium chloride intravenous infusion and the injectable sterile powder and the aseptic block that make with freeze-drying or spray drying method.

Of the present invention have human body immunity improving power, the treatment cardiovascular and cerebrovascular disease traditional medicine Injectio in contain saponin component, polysaccharide composition and flavones ingredient, calculate according to weight ratio, wherein the content of saponin component is not less than 1% of the total solid after the deduction adjuvant amount and water quantities in the preparation; The content of scutellarin should be 80%～120% of labelled amount in the preparation, the content of polysaccharide composition is not less than in the preparation 3% of total solid after deduction adjuvant amount and the water quantities, and all can survey the saponin component in the preparation, polysaccharide composition, flavones ingredient and other the composition sum and be not less than 25% of the total solid after the deduction adjuvant amount and water quantities in the preparation.

Preparation method with traditional medicine Injectio of human body immunity improving power, treatment cardiovascular and cerebrovascular disease of the present invention: Radix Ophiopogonis, Radix Ginseng, Fructus Schisandrae Chinensis three flavor medical materials add water or ethanol extraction respectively, extracting solution carry out suitably concentrating crude extract or further adopt one or more methods in alcohol deposition method, acid-base precipitation method, column chromatography, the solvent extraction to mix to use refining extract, material crude extract or refining extract and the breviscapine adding different auxiliary material of getting it filled is made various ejection preparations.

Specifically: the preparation method of the ejection preparation of treatment cardiovascular and cerebrovascular disease of the present invention is:

A, Radix Ophiopogonis medical material, adding 5～15 times of volume decoctings boils 1～4 time, each 0.5～2.5 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 50～70%, make that to contain the alcohol amount be 80～90% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 1～4 times of water dissolution, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, schisandra chinensis medicinal material, add 5～15 times of decoctings and boil 1～4 time, each 0.5～2.5 hour, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 50～70% for the first time, make for the second time that to contain the alcohol amount be 80～90%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 5～15 times of volume 50～80% alcohol reflux 1～4 time, each 0.5～2.5 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add adjuvant and make different ejection preparations.

Injection of the present invention prepares like this:

A, get medical material Radix Ophiopogonis, adding 10 times of volume decoctings boils 3 times, each 1.5 hours, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 60%, make that to contain the alcohol amount be 85% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 2 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, schisandra chinensis medicinal material, add 10 times of decoctings and boil 3 times, each 1.5 hours, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 60% for the first time, make for the second time that to contain the alcohol amount be 85%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 10 times of volume 70% alcohol reflux 3 times, each 1 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfers pH value 5.5～7.5, boils, spend the night coarse filtration, fine straining 1～8 ℃ of cold preservation.Mannitol is added the injection water be mixed with 50～150mg/ml solution,, filter packing with above-mentioned filtrate mixing, temperature-55～-45 ℃, pre-freeze time 8～12h, the beginning evacuation, and be warming up to-43～-37 ℃, keep 6～10h, be warming up to-33～-27 ℃ again, keep 6～10h; Be warming up to-23～-17 ℃, keep 6～10h, be warming up to-13～-7 ℃, keep 4～6h, be warming up to-3～3 ℃, keep 4～6h, be warming up to 7～13 ℃, keep 1～3h, be warming up to 17～23 ℃, keep 1～3h, promptly get freeze-dried powder.

The adjuvant that is adopted in the preparation process of the present invention comprises one or more in mannitol, galactose, glycine, glucose, sodium chloride, dextran, glycerol, ethanol, propylene glycol, Polyethylene Glycol, sorbitol, tween, the poloxamer.

Injection of the present invention prepares like this:

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, adjust pH 5.5～7.5 boils, and spends the night 1～8 ℃ of cold preservation, coarse filtration, fine straining, dividing to install in the ampoule bottle, is 100～110 ℃ in vapor (steam) temperature, and actual pressure is at 100～120kN/m ³Pressure sterilizing is 40～60 minutes under the condition, promptly gets the injection with small volume or the concentrated solution for injection that are directly used in drug administration by injection.

Injection of the present invention prepares like this:

B, get schisandra chinensis medicinal material, add 10 times of decoctings and boil 3 times, each 1.5 hours, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 60% for the first time, make for the second time that to contain the alcohol amount be 85%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, the glucose that adds ormal weight again, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night 1～8 ℃ of cold preservation, coarse filtration, fine straining, add the injection water, packing is under 105～125 ℃ of conditions, sterilized 20～60 minutes, and promptly got the glucose intravenous infusion agent.

Injection of the present invention prepares like this:

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, the sodium chloride that adds ormal weight again, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night 1～8 ℃ of cold preservation, coarse filtration, fine straining, add the injection water, packing is under 105～125 ℃ of conditions, sterilized 20～60 minutes, and promptly got the sodium chloride intravenous infusion agent.

Injection of the present invention prepares like this:

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, and adjust pH 5.5～7.5 boils, spend the night 1～8 ℃ of cold preservation, coarse filtration, fine straining divide to install in the enamel tray, temperature-55～-45 ℃, pre-freeze time 8～12h, the beginning evacuation, and be warming up to-43～-37 ℃, keep 6～10h, be warming up to-33～-27 ℃ again, keep 6～10h; Be warming up to-23～-17 ℃, keep 6～10h, be warming up to-13～-7 ℃, keep 4～6h, be warming up to-3～3 ℃, keep 4～6h, be warming up to 7～13 ℃, keep 1～3h, be warming up to 17～23 ℃, keep 1～3h, under aseptic condition, divide to install to promptly to get the freeze dry sterile powder end in the cillin bottle.

Injection of the present invention prepares like this:

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night 1～8 ℃ of cold preservation, coarse filtration, fine straining, in inlet temperature is 140～160 ℃, and leaving air temp is 60～80 ℃, and air velocity is 16～20ms ^-1Condition under spray drying get powder, packing promptly gets the spray drying sterilized powder.

The applicant has carried out a series of experiments, can prove that safety of medicine provided by the invention is effective, process stabilizing, quality controllable.

Experimental example 1: drug effectiveness research

The pharmacological research conclusion

Of the present invention group of SHENGMAI ZHUSHEYE group of pilot project breviscapus pulse-engendering Capsules group

Anti-mouse tail thrombotest effect is remarkable, and the general effect of effect reinforced effects is general

Rabbit fibrin solubility test effect is obvious, and the general effect of effect reinforced effects is general

Blood circulation promoting and blood stasis dispelling test effect remarkable result positive effect is obvious

The not obvious DeGrain of white mice anti-fatigue test effect remarkable result

From above-mentioned test as can be seen, therefore the injection therapeutic effect proves that said preparation is effective significantly better than oral direct.

Experimental example 2: injection with small volume or concentrated solution for injection molding research

(1) activated carbon dosage is investigated:

Injection owing to solvent, raw material, container etc. have the pyrogen material, reduces the safety of injection in the process of producing, and therefore needs to remove the pyrogen material in the process of preparation injection.The method of depyrogenation mainly contains high temperature method, acid-base method, ultrafiltration and absorption method at present, active carbon adsorption not only can heat of adsorption originality composition, the effect that also has filter of helping and decolouring, when removing pyrogen, can improve the appearance character of preparation, therefore we select the active carbon adsorption depyrogenation for use, and its consumption is investigated.The results are shown in following table:

The activated carbon dosage investigation table

Heavy (g) rate of transform (%) outward appearance of activated carbon dosage (%) cream

0.1 9.62 60.45 is reddish brown

1 9.79 59.04 is red

1.5 9.64 56.28 is red

From the medicinal liquid outward appearance, select activated carbon dosage be 1% and 1.5% proper; But judge that from the rate of transform 0.1% consumption and 1% consumption are slightly better, the three all can satisfy the related request of injection, but takes all factors into consideration above factor, so that be the best with the activated carbon decolorizing of medicine liquid volume 1%.

The bleaching time investigation table

Time (minute) heavy (g) rate of transform (%) outward appearance of cream

10 10.59 61.31 is reddish brown

30 9.84 59.49 is red

60 9.64 57.26 is pale red

From top test as can be seen, along with the color of the prolongation medicinal liquid of time is thin out, but above-mentioned factor is taken all factors into consideration in the also corresponding minimizing of the rate of transform of effective ingredient, selects for use and boils 30 minutes for best.

(2) pH value of solution is investigated

For adapting to the Human Physiology needs, also to consider the character of each constituents in the medicinal liquid simultaneously, when dosing, need suitably adjust the pH value of medicinal liquid.Select scutellarin content as evaluation index.

Test method and result: after feeding intake and handle by recipe quantity,, filter with the concentrated solution mix homogeneously by above-mentioned condition, add water to 1000ml, adjust pH is when the different pH value that reaches shown in the following table, boil the back standing over night, observe the variation of appearance character under different pH condition.Experimental result sees Table:

The investigation of dosing pH value

Sequence number 123456789

Dosing pH 4.5 5.0 5.5 6.0 6.5 7.0 7.5 8.0 8.5

Boil pH 4.0 4.4 5.2 5.7 6.1 6.7 7.0 7.7 8.0

The no significant change color burn of precipitation appears in outward appearance

The result shows, medicinal liquid boils the back pH value and occurs precipitating at the sample 5.5 below, and pH value is obviously deepened in the color sample more than 7.5, and pH value is that 5.5～7.5 medicinal liquid is relatively stable, and outward appearance does not have significant change.Below its scutellarin content is measured.The results are shown in Table:

The situation of change table of index components before and after pH value is regulated

PH boiled back content (%) after content (%) boiled during sequence number dosing pH dosing

1 5.5 2.62 5.2 2.38

2 6.0 2.62 5.8 2.19

3 6.5 2.62 6.1 2.54

4 7.0 2.62 6.7 2.48

5 7.5 2.62 7.1 2.68

As seen from table, medicinal liquid is being adjusted the pH value front and back, the not too big variation of index components scutellarin content.The appearance character of comprehensive above-mentioned medicinal liquid and the changes of contents of scutellarin, the pH value of medicinal liquid is transferred between 5.5～7.5 when determining dosing.

Experimental example 3: the investigation of freeze-dry process

(1) screening of caffolding agent kind

The caffolding agent kind influences the molding of freeze-dried powder, so at first this is screened.Taking liquid mixes with caffolding agent mannitol, glucose and lactose solution respectively, 0.22 μ m membrane filtration postlyophilization, every XiLin bottle-packaging solution 3ml.Freeze dryer: Edwards SNL-3200 freezer dryer (the thermoelectric Thermo of the U.S.).Lyophilisation condition :-45 ℃, behind the pre-freeze 8h, the beginning evacuation, and be warming up to-40 ℃, keep 10h; Be warming up to-30 ℃, keep 10h; Be warming up to-20 ℃, keep 10h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 15 ℃, keep 3h; Be warming up to 25 ℃, keep 3h.The result is as showing:

The screening of caffolding agent kind

Caffolding agent kind caffolding agent: medicinal liquid solubility finished product outward appearance

(V∶V)

2: 1 good parts of glucose subside

Galactose general molding in 2: 1

Mannitol good molding in 2: 1

Glycine good molding in 2: 1, frangible

Dextran general molding in 2: 1

Mannitol, propylene glycol good molding in 2: 1

Glycine, Polyethylene Glycol good molding in 2: 1, frangible

Dextran, Pyrusussuriensis good molding in 2: 1

Alcohol, tween

Blank medicinal liquid 3ml atrophy

As seen from table, in the adjuvant that is screened, under the identical situation of other conditions, most of adjuvant all can be made into freeze-dried powder, but solubility angle integrated survey from yield rate, molding situation and sample, use the effect of mannitol to be better than other several adjuvants separately, can satisfy the every requirement of injection, reduce simultaneously as far as possible and add too much adjuvant.

(2) caffolding agent consumption screening

The mannitol solution (50mg/ml, 100mg/ml and 150mg/ml) of variable concentrations is mixed in varing proportions with medicinal liquid, filter, every cillin bottle loading amount is 3ml, lyophilization.Lyophilisation condition :-45 ℃, behind the pre-freeze 8h, the beginning evacuation, and be warming up to-40 ℃, keep 10h; Be warming up to-30 ℃, keep 10h; Be warming up to-20 ℃, keep 10h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 15 ℃, keep 3h; Be warming up to 25 ℃, keep 3h.The result is as showing:

The screening of mannitol consumption

Mannitol concentration mannitol: medicinal liquid

Numbering color and luster profile solubility clarity

(mg/ml) (v∶v)

1 50 2: 1 yellowish-brown part has been subsided up to specification

2 100 2: 1 is yellow intact good up to specification

3 150 2: 1 is yellowish intact good up to specification

As seen from table, when the ratio of caffolding agent consumption and medicinal liquid is 2: 1, the sample character is that the sample of 100mg/ml and 150mg/ml is relatively good with the mannitol concentration, the sample of 50mg/ml has part to subside, but major part still is molding, but take all factors into consideration the consumption and the clinical dose of adjuvant, the optimum selection mannitol concentration is 100mg/ml, and the volume ratio of mannitol solution and medicinal liquid is 2: 1.

(3) lyophilization conditional filtering

Lyophilization is a veryer long dry run, needs to consume a large amount of energy.An ideal lyophilisation condition not only can be saved a large amount of energy, can also shorten man-hour simultaneously, so we are optimized screening to existing lyophilisation condition.The actual conditions screening sees Table:

The lyophilization conditional filtering

Time (h)

Condition I condition II condition III cold-trap

Temperature (℃)

-45 (pre-freezes) 8-8

-40 (pre-freeze)-8-

-40 (evacuation) 8-10

-35 (evacuation)-8-

-30 (evacuation) 8-10

-25 (evacuation)-8-

-20 (evacuation) 8-10

-15 (evacuation)-8-maintenance

5-5-70 ℃ of-10 (evacuation)

0 (evacuation) 555

10 (evacuation) 243

20 (evacuation) 243

Experimental result shows: finished product appearance character that condition I, II and III make and the equal conformance with standard of moisture.But comparatively speaking, condition II yield rate is low slightly, and condition III power consumption is bigger, considers the practical situation of production, short condition I of finally selected overall time spent, i.e. and lyophilization condition is: pre-freeze temperature-45 ℃, pre-freeze time 10h;-40 ℃ of evacuation keep 8h; Be warming up to-30 ℃ again, keep 8h; Be warming up to-20 ℃, keep 8h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 10 ℃, keep 2h; Be warming up to 20 ℃, keep 2h, get product.

Experimental example 4: spray drying conditional filtering

Spray drying technology can make sample dry rapidly under the situation of atomizing, and the protection effective ingredient can make the water content of sample reduce simultaneously, helps stability of formulation.It is bigger that but the air temperature and current speed that spray-dired effect is imported and exported influences, so we are that evaluation index is investigated these three factors with the loss of active ingredients rate.

Spray drying condition investigation table

Inlet temperature (℃) outlet temperature (℃) air velocity (ms ^-1) loss rate (%)

140 60 16 4.68

150 70 18 4.10

160 80 20 4.29

From above-mentioned result of the test as can be seen, three kinds of conditions all can obtain material preferably, but are 150 ℃ with inlet temperature by contrast, and outlet temperature is 70 ℃, and air velocity is 18ms ^-1Condition be best.

Concrete embodiment

(part is represented weight portion, as: kilogram, gram etc.)

Embodiments of the invention 1: 30 parts of 300 parts of breviscapines of 300 parts of Fructus Schisandrae Chinensis of 500 parts of Radix Ginsengs Radix Ophiopogonis

A, get medical material Radix Ophiopogonis, adding 15 times of volume decoctings boils 4 times, each 2.5 hours, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 70%, make that to contain the alcohol amount be 90% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 1 times of water dissolution, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 15 times of decoctings and boil 4 times, each 2.5 hours, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 70% for the first time, make for the second time that to contain the alcohol amount be 90%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 15 times of volume 80% alcohol reflux 4 times, each 2.5 hours, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 1% active carbon, boil, keep little 30min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfers pH value 5.5～7.5, boils, spend the night coarse filtration, fine straining 4 ℃ of cold preservations.Mannitol is added the injection water be mixed with 100mg/ml solution,, filter, packing, temperature-45 ℃, pre-freeze time 10h with above-mentioned filtrate mixing;-40 ℃ of evacuation keep 8h; Be warming up to-30 ℃ again, keep 8h; Be warming up to-20 ℃, keep 8h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 10 ℃, keep 2h; Be warming up to 20 ℃, keep 2h, promptly get freeze-dried powder.After testing: Radix Ophiopogonis polysaccharide content accounts in the preparation 47% of total solid after deduction adjuvant amount and the water quantities; The content of saponin component accounts in the preparation 29% of total solid after deduction adjuvant amount and the water quantities; All can be surveyed the composition sum and account in the preparation 90% of total solid after deduction adjuvant amount and the water quantities.

Embodiments of the invention 2: 0.1 part of 1 part of breviscapine of 1 part of Fructus Schisandrae Chinensis of 10 parts of Radix Ginsengs Radix Ophiopogonis

A, get medical material Radix Ophiopogonis, adding 5 times of volume decoctings boiled 1 time 0.5 hour, measuring relative density when extracting solution is concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 50%, make for the second time that to contain the alcohol amount be 80%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 1 times of water dissolution, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, adding 5 times of decoctings boiled 1 time 0.5 hour, merge extractive liquid, adds the medicinal liquid mixing after the above-mentioned distillation, and measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 50%, make that to contain the alcohol amount be 80% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, added 5 times of volumes, 50% alcohol reflux 1 time 0.5 hour, measuring relative density when extracting solution is concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1% active carbon, boil, keep little 60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night 8 ℃ of cold preservations, coarse filtration, fine straining, dividing to install in the ampoule bottle, is 110 ℃ in vapor (steam) temperature, and actual pressure is at 120kN/m ³Pressure sterilizing is 60 minutes under the condition, promptly gets the injection with small volume or the concentrated solution for injection that are directly used in drug administration by injection.After testing: Radix Ophiopogonis polysaccharide content accounts in the preparation 22% of total solid after deduction adjuvant amount and the water quantities; The content of saponin component accounts in the preparation 2.2% of total solid after deduction adjuvant amount and the water quantities; Polysaccharide composition, saponin component and scutellarin three sum account in the preparation 25% of total solid after deduction adjuvant amount and the water quantities.

Embodiments of the invention 3: 2 parts of 60 parts of breviscapines of 60 parts of Fructus Schisandrae Chinensis of 110 parts of Radix Ginsengs Radix Ophiopogonis

A, get medical material Radix Ophiopogonis, adding 5 times of volume decoctings boiled 1 time 0.5 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 50%, make for the second time that to contain the alcohol amount be 80%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, will twice precipitation merges the back and adds 4 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, and measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 10 times of decoctings and boil 3 times, each 1 hour, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 60% for the first time, make for the second time that to contain the alcohol amount be 80%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, added 5 times of volumes, 50% alcohol reflux 1 time 0.5 hour, measuring relative density when extracting solution is concentrated into 60 ℃ is 1.05～1.15, add 4 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, and measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ginseng extract that gets;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, add the glucose of ormal weight again, by volume add 0.1% active carbon, boil, keep little 10min that boils, cold slightly filtration, filtrate add the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night coarse filtration, fine straining 1 ℃ of cold preservation, add the injection water, packing is under 105 ℃ of conditions, sterilized 20 minutes, and promptly got the glucose intravenous infusion agent.After testing: polyoses content accounts in the preparation 74% of total solid after deduction adjuvant amount and the water quantities; The content of saponin component accounts in the preparation 3.4% of total solid after deduction adjuvant amount and the water quantities.

Embodiments of the invention 4: 0.5 part of 60 parts of breviscapine of 60 parts of Fructus Schisandrae Chinensis of 110 parts of Radix Ginsengs Radix Ophiopogonis

A, get medical material Radix Ophiopogonis, adding 8 times of volume decoctings boils 2 times, each 1.5 hours, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 70%, make that to contain the alcohol amount be 85% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 1 times of water dissolution, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 12 times of decoctings and boil 3 times, each 1 hour, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 70% for the first time, make for the second time that to contain the alcohol amount be 85%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 8 times of volume 70% alcohol reflux 3 times, each 1 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, add the sodium chloride of ormal weight again, by volume add 1% active carbon, boil, keep little 30min that boils, cold slightly filtration, filtrate add the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night coarse filtration, fine straining 4 ℃ of cold preservations, add the injection water, packing is under 115 ℃ of conditions, sterilized 30 minutes, and promptly got the sodium chloride intravenous infusion agent.After testing: the content of saponin component accounts in the preparation 11.5% of total solid after deduction adjuvant amount and the water quantities.

Embodiments of the invention 5: 0.1 part of 6 parts of breviscapine of 6 parts of Fructus Schisandrae Chinensis of 11 parts of Radix Ginseng Rubra Radix Ophiopogonis

A, add 10 times of volumes, 80% alcohol reflux Radix Ophiopogonis 3 times, each 1 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the dissolving of 3 times of amount water for injection, filter merging filtrate, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, and medicinal residues add 5 times of volume decoctings and boil 2 times, merge extractive liquid,, concentrating and measuring relative density when adding to 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 60% for the first time, make for the second time that to contain the alcohol amount be 85%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, will twice precipitation merges the back and adds 2 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, and measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 8 times of decoctings and boil 1 time, each 0.5 hour, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 60% for the first time, make for the second time that to contain the alcohol amount be 90%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the Radix Ginseng Rubra medical material, adding 10 times of volume decoctings boils 3 times, each 1 hour, measuring relative density when merge extractive liquid, is concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 60%, make for the second time that to contain the alcohol amount be 85%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, will twice precipitation merges the back and adds 2 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, and measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ginseng Rubra extract that gets;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng Rubra extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night 1～8 ℃ of cold preservation, coarse filtration, fine straining, divide to install in the enamel tray temperature-45 ℃, pre-freeze time 10h;-40 ℃ of evacuation keep 8h; Be warming up to-30 ℃ again, keep 8h; Be warming up to-20 ℃, keep 8h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 10 ℃, keep 2h; Be warming up to 20 ℃, keep 2h, under aseptic condition, divide to install to promptly to get the freeze dry sterile powder end in the cillin bottle.After testing: polyoses content accounts in the preparation 47% of total solid after deduction adjuvant amount and the water quantities, still contains the Radix Ginseng Rubra polysaccharide except that containing Radix Ophiopogonis polysaccharide; The content of saponin component accounts in the preparation 12% of total solid after deduction adjuvant amount and the water quantities.

Embodiments of the invention 6: 1 part of 6 parts of breviscapine of 6 parts of Fructus Schisandrae Chinensis of 11 parts of Radix Codonopsis Radix Ophiopogonis

A, get medical material Radix Ophiopogonis, adding 10 times of volume decoctings boils 2 times, each 1 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 60%, make that to contain the alcohol amount be 85% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 2 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 8 times of decoctings and boil 3 times, each 1 hour, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 70% for the first time, make for the second time that to contain the alcohol amount be 80%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get codonopsis pilosula, added 6 times of volumes, 50% alcohol reflux 1 time 0.5 hour, measuring relative density when extracting solution is concentrated into 60 ℃ is 1.05～1.15, dry Radix Codonopsis extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Codonopsis extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.8% active carbon, boil, keep little 40min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, adjust pH 5.5～7.5 boils, and spends the night 6 ℃ of cold preservations, coarse filtration, fine straining, in inlet temperature is 150 ℃, and leaving air temp is 70 ℃, and air velocity is 18ms ^-1Condition under spray drying get powder, packing promptly gets the spray drying sterilized powder.

Embodiments of the invention 7: 0.8 part of 1 part of breviscapine of 1 part of Fructus Schisandrae Chinensis of 10 parts of Radix Ginsengs Radix Ophiopogonis

A, get medical material Radix Ophiopogonis, adding 7 times of volume decoctings boiled 1 time 0.5 hour, measuring relative density when extracting solution is concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 50%, make that to contain the alcohol amount be 80% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Radix Ophiopogonis extract;

B, get schisandra chinensis medicinal material, added 5 times of volume water boiling and extraction 1 time 1.5 hours, measuring relative density when extracting solution is concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 50%, make that to contain the alcohol amount be 80% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1% active carbon, boil, keep little 60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night 8 ℃ of cold preservations, coarse filtration, fine straining, dividing to install in the ampoule bottle, is 110 ℃ in vapor (steam) temperature, and actual pressure is at 120kN/m ³Pressure sterilizing is 60 minutes under the condition, promptly gets the injection with small volume or the concentrated solution for injection that are directly used in drug administration by injection.After testing: Radix Ophiopogonis polysaccharide content accounts in the preparation 3.05% of total solid after deduction adjuvant amount and the water quantities.

Embodiments of the invention 8: 5 parts of 6 parts of breviscapines of 6 parts of Fructus Schisandrae Chinensis of 11 parts of Radix Ginsengs Radix Ophiopogonis

A, get medical material Radix Ophiopogonis, adding 10 times of volume decoctings boils 2 times, each 1.5 hours, merge extractive liquid,, merge extractive liquid,, filter, filtrate is crossed ZTC-1 type macroporous adsorptive resins with the speed of 0.5ml/g medical material .min, water with 6 times of resin volumes washes with the speed of 0.5ml/g medical material .min earlier, and 15% ethanol of 4 times of resin volumes of reuse is used the speed eluting of 70% ethanol of 4 times of resin volumes with 0.8ml/g medical material .min at last with the speed eluting impurity of 1.2ml/g medical material .min, collect stripping liquid, reclaim ethanol, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 10 times of volume water boiling and extraction 3 times, each 1 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 70%, make that to contain the alcohol amount be 85% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 10 times of volume 60% alcohol reflux 2 times, each 1 hour, merge extractive liquid,, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, the water dissolution that adds 4 times of medical material volumes, filter, filtrate is crossed ZTC-1 type macroporous adsorbent resin with the speed of 0.5ml/g medical material .min, use 7 times of resinite hydrops and 5 times of resin volume 10% alcohol flushing impurity successively, use 60% alcohol desorption of 5 times of resin volumes then, collect stripping liquid, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 0.1%～1.5% active carbon, boil, keep little 10～60min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, transfer pH value 5.5～7.5, boil, spend the night 1～8 ℃ of cold preservation, coarse filtration, fine straining, divide to install in the enamel tray temperature-45 ℃, pre-freeze time 10h;-40 ℃ of evacuation keep 8h; Be warming up to-30 ℃ again, keep 8h; Be warming up to-20 ℃, keep 8h; Be warming up to-10 ℃, keep 5h; Be warming up to 0 ℃, keep 5h; Be warming up to 10 ℃, keep 2h; Be warming up to 20 ℃, keep 2h, under aseptic condition, divide to install to promptly to get the freeze dry sterile powder end in the cillin bottle.After testing: carbohydrate content content accounts in the preparation 4.3% of total solid after deduction adjuvant amount and the water quantities.

Claims

One kind have human body immunity improving power, the treatment cardiovascular and cerebrovascular disease traditional medicine Injectio, it is characterized in that: calculate according to components by weight percent, it is refiningly added suitable adjuvant and is made through extracting by 0.1～30 part of 1～300 part of 10～500 parts of Radix Ophiopogonis, 1～300 part of Radix Ginseng, Fructus Schisandrae Chinensis and breviscapine, or add suitable adjuvant and be made through extracting the extract that obtains after refining and corresponding weight portion breviscapine by corresponding weight portion medical material, and contain the various saccharides composition in the preparation, do not extract the Fructus Schisandrae Chinensis volatile oil constituents separately.
2. has human body immunity improving power according to claim 1 is described, the traditional medicine Injectio of treatment cardiovascular and cerebrovascular disease, it is characterized in that: calculate according to components by weight percent, it is by 50～200 parts of Radix Ophiopogonis, 10～100 parts of Radix Ginsengs, 0.3～15 part of 10～100 parts of Fructus Schisandrae Chinensis and breviscapine refiningly add suitable adjuvant and are made through extracting, or add suitable adjuvant and be made through extracting the extract that obtains after refining and corresponding weight portion breviscapine by corresponding weight portion medical material, and contain various saccharides compositions such as Radix Ophiopogonis polysaccharide and monosaccharide in the preparation, do not extract the Fructus Schisandrae Chinensis volatile oil constituents separately.
3. describedly has human body immunity improving power according to claim 1 or 2, the traditional medicine Injectio of treatment cardiovascular and cerebrovascular disease, it is characterized in that: calculate according to components by weight percent, it is by 80～150 parts of Radix Ophiopogonis, 30～80 parts of Radix Ginsengs, 0.5～8 part of 30～80 parts of Fructus Schisandrae Chinensis and breviscapine are made through extracting refining and adding suitable adjuvant, or add suitable adjuvant and be made through extracting the extract that obtains after refining and corresponding weight portion breviscapine by corresponding weight portion medical material, and contain various saccharides compositions such as Radix Ophiopogonis polysaccharide and monosaccharide in the preparation, do not extract the Fructus Schisandrae Chinensis volatile oil constituents separately, calculate according to weight ratio, the content of carbohydrate content is not less than 4% of the total solid after the deduction adjuvant amount and water quantities in the preparation.
4. according to any described traditional medicine Injectio with human body immunity improving power, treatment cardiovascular and cerebrovascular disease of claim 1-3, it is characterized in that: injection comprises: be directly used in drug administration by injection injection, need to be used for after the dilution concentrated solution for injection of intravenous drip, directly for the glucose intravenous infusion of intravenous drip and sodium chloride intravenous infusion and the injectable sterile powder and the aseptic block that make with freeze-drying or spray drying method.
5. according to the described traditional medicine Injectio of claim 4 with human body immunity improving power, treatment cardiovascular and cerebrovascular disease, it is characterized in that: contain saponin component, polysaccharide composition and flavones ingredient in the preparation, calculate according to weight ratio, wherein the content of saponin component is not less than 1% of the total solid after the deduction adjuvant amount and water quantities in the preparation; The content of scutellarin should be 80%～120% of labelled amount in the preparation, and the content of polysaccharide composition is not less than 3% of the total solid after the deduction adjuvant amount and water quantities in the preparation.
6. according to the described traditional medicine Injectio of claim 5 with human body immunity improving power, treatment cardiovascular and cerebrovascular disease, it is characterized in that: calculate according to weight ratio, all can survey the saponin component in the preparation, polysaccharide composition, flavones ingredient and other the composition sum and be not less than 25% of the total solid after the deduction adjuvant amount and water quantities in the preparation.
7. the preparation method with traditional medicine Injectio of human body immunity improving power, treatment cardiovascular and cerebrovascular disease as claimed in claim 4, it is characterized in that: Radix Ophiopogonis, Radix Ginseng, Fructus Schisandrae Chinensis three flavor medical materials add water or ethanol extraction respectively, extracting solution carry out suitably concentrating crude extract or further adopt one or more methods in alcohol deposition method, acid-base precipitation method, column chromatography, the solvent extraction to mix to use refining extract, material crude extract or refining extract and the breviscapine adding different auxiliary material of getting it filled is made various ejection preparations.
8. the preparation method with traditional medicine Injectio of human body immunity improving power, treatment cardiovascular and cerebrovascular disease as claimed in claim 7 is characterized in that:

A, get medical material Radix Ophiopogonis, adding 5～15 times of volume decoctings boils 1～4 time, each 0.5～2.5 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 50～70%, make that to contain the alcohol amount be 80～90% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 1～4 times of water dissolution, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 5～15 times of decoctings and boil 1～4 time, each 0.5～2.5 hour, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 50～70% for the first time, make for the second time that to contain the alcohol amount be 80～90%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 5～15 times of volume 50～80% alcohol reflux 1～4 time, each 0.5～2.5 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add adjuvant and make different ejection preparations.
9. according to the described preparation method of claim 8, it is characterized in that with traditional medicine Injectio of human body immunity improving power, treatment cardiovascular and cerebrovascular disease:

A, get medical material Radix Ophiopogonis, adding 10 times of volume decoctings boils 3 times, each 1.5 hours, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 60%, make that to contain the alcohol amount be 85% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 2 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 10 times of decoctings and boil 3 times, each 1.5 hours, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 60% for the first time, make for the second time that to contain the alcohol amount be 85%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 10 times of volume 70% alcohol reflux 3 times, each 1 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add adjuvant and make different ejection preparations.
10. according to the described preparation method with traditional medicine Injectio of human body immunity improving power, treatment cardiovascular and cerebrovascular disease of claim 9, it is characterized in that: lyophilized injectable powder is preparation like this:

A, get medical material Radix Ophiopogonis, adding 10 times of volume decoctings boils 3 times, each 1.5 hours, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, add the ethanol precipitate with ethanol twice, make for the first time that to contain the alcohol amount be 60%, make that to contain the alcohol amount be 85% for the second time, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, twice precipitation merged the back add 2 times of water dissolutioies, filter, the concentrated solution of filtrate and front merges, measuring relative density when being evaporated to 60 ℃ is 1.05～1.15, the dry Radix Ophiopogonis extract that gets;

B, get schisandra chinensis medicinal material, add 10 times of decoctings and boil 3 times, each 1.5 hours, merge extractive liquid,, add the medicinal liquid mixing after the above-mentioned distillation, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, adds ethanol precipitate with ethanol twice, makes that to contain the alcohol amount be 60% for the first time, make for the second time that to contain the alcohol amount be 85%, filter merging filtrate, measuring relative density during decompression recycling ethanol to 60 ℃ is 1.05～1.15, dry Fructus Schisandrae Chinensis extrat;

C, get the ginseng crude drug, add 10 times of volume 70% alcohol reflux 3 times, each 1 hour, merge extractive liquid,, measuring relative density when being concentrated into 60 ℃ is 1.05～1.15, dry Radix Ginseng extract;

Above-mentioned Radix Ophiopogonis extract, Fructus Schisandrae Chinensis extrat, Radix Ginseng extract and breviscapine are merged, add an amount of water for injection dissolving, by volume add 1.0% active carbon, boil, keep little 30min that boils, cold slightly filtration, filtrate adds the injection water to ormal weight, and adjust pH 5.5～7.5 boils, spend the night coarse filtration, fine straining 4 ℃ of cold preservations.Suitable adjuvant is added the injection water is mixed with solution,, filter with above-mentioned filtrate mixing, packing, temperature-45 ℃, pre-freeze time 10h, the beginning evacuation, and in 12～72 hours differential gradient increased temperature to 10 ℃ progressively, keep 2h, be warming up to 20 ℃, keep 2h, promptly.
11. according to any described preparation method with traditional medicine Injectio of human body immunity improving power, treatment cardiovascular and cerebrovascular disease among the claim 7-10, it is characterized in that: the adjuvant that is adopted in the preparation comprises one or more in mannitol, galactose, glycine, glucose, sodium chloride, dextran, glycerol, ethanol, propylene glycol, Polyethylene Glycol, sorbitol, tween, the poloxamer.
12. according to claim 1-3 and any described traditional medicine Injectio with human body immunity improving power, treatment cardiovascular and cerebrovascular disease of 7-10, it is characterized in that: Radix Ginseng can also be the Radix Ginseng Rubra or the Radix Codonopsis of equivalent.